GlaxoSmithKline (GSK) plans to spend more than $1B boosting stakes in its Indian and Nigerian...


GlaxoSmithKline (GSK) plans to spend more than $1B boosting stakes in its Indian and Nigerian units to strengthen ownership of its consumer businesses in fast-growing markets. GSK says it will buy an additional 31.8% share of its Indian unit for ~$940M, giving it a 75% stake, and increase its ownership of the Nigerian unit to 80% from 46.4% for ~$98M. GSK -0.8% premarket.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs